Position in RDY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,220,029
-$53,921 QoQ
Shares Held
84,198
-8.5% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 238 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $670,557,120 across 30 Drug Manufacturers - Specialty & Generic names. RDY ranks #23 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
923,125 | $155,583,487 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
249,056 | $134,946,012 | |
| 3 | ALKS |
Alkermes plc.
|
2,421,016 | $126,861,238 | |
| 4 | ZTS |
Zoetis Inc.
|
1,435,652 | $103,165,952 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,114,912 | $33,902,039 | |
| 6 | LQDA |
Liquidia Corp
|
301,432 | $24,033,173 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,120,469 | $11,204,690 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
614,206 | $10,631,905 |
All Filings in RDY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,220,029 | 84,198 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,273,950 | 91,982 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $807,201 | 57,493 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $732,398 | 52,389 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $986,749 | 65,652 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $702,525 | 53,262 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,001,543 | 63,429 | Shares | Sole | 2025-02-13 | |
| 2023-06-30 | $339,026 | 5,372 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $243,034 | 4,269 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,113,590 | 60,166 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $5,436,974 | 103,878 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,245,543 | 94,702 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,385,912 | 42,812 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,882,749 | 44,072 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $7,332,614 | 112,567 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $11,155,804 | 151,759 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $11,554,887 | 188,221 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $12,013,006 | 168,509 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $8,540,924 | 122,785 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $6,794,821 | 128,180 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $4,956,073 | 122,888 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||